Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel D. De Carvalho"'
Publikováno v:
Nature Reviews Cancer. 19:151-161
DNA methylation inhibitors have become the mainstay for treatment of certain haematological malignancies. In addition to their abilities to reactivate genes, including tumour suppressors, that have acquired DNA methylation during carcinogenesis, they
Autor:
Reema Deol, Tiago Medina, Rahul Shinde, Marie Jo Halaby, Yuriy Baglaenko, Zahi Touma, Sathi Babu Chodisetti, Kieran P. Manion, Haiyun Liu, Maria Eldh, Sara Lamorte, Kapil Chaudhary, Andreas Kloetgen, Drew Wallace, Kebria Hezaveh, Tracy L. McGaha, Ankur Chakravarthy, Aristotelis Tsirigos, David H. Munn, Joan E. Wither, Susanne Gabrielsson, Michael P. Madaio, Daniel D. De Carvalho, Buvana Ravishankar
Publikováno v:
Nature Immunology. 19:571-582
The transcription factor AhR modulates immunity at multiple levels. Here we report that phagocytes exposed to apoptotic cells exhibited rapid activation of AhR, which drove production of the cytokine IL-10. Activation of AhR was dependent on interact
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Nature Communications
Nature Communications
The extracellular matrix (ECM) is a key determinant of cancer progression and prognosis. Here we report findings from one of the largest pan-cancer analyses of ECM gene dysregulation in cancer. We define a distinct set of ECM genes upregulated in can
Autor:
Anamélia Lorenzetti Bocca, Tarciane Silva de Araújo, Viviane Furlan Lozano, Daniel D. De Carvalho, Yanna Karla de Medeiros Nóbrega
Publikováno v:
Mycopathologia. 170:89-98
Chromoblastomycosis is a chronic, suppurative and granulomatous mycosis whose main etiologic agent is the fungus Fonsecaea pedrosoi. The severity of chromoblastomycosis clinical manifestations correlates with the Th1 or Th2 immune response, and an ef